Randomized prospective study on the role of high dose rate intraluminal brachytherapy (HDRILBT) in palliation of symptoms in advanced non small cell lung cancer (NSCLC) treated with radiation alone

03 medical and health sciences 0302 clinical medicine
DOI: 10.1016/j.ijrobp.2004.06.152 Publication Date: 2004-09-14T21:03:33Z